NEW YORK (MarketWatch) � Shares of the following companies made notable moves ahead of Friday�s U.S. stock market:
AdvancersCepheid CPHD �shares leapt nearly 26% after the diagnostics company late Thursday reported better-than-expected fourth-quarter results.
MARKETS | Expanded markets coverage�The Tell: Market news and analysis
� U.S. and Canada markets |Canada section
� European and Middle Eastern markets
� Asia � from Japan to China to Australia
� Latin America: Brazil, Argentina, Mexico, more
TOOLS AND DATA | Markets data menu
� My Portfolio: Know where your funds are?
�Real-time currency exchange rates
�After-hours stock screener
market SECTORS
�Financials
�Bonds
�Energy
�Airlines�Tech Stocks
�Metals
�Telecom
�Biotech�Oil news
�Retail
�Key indexes
�ETF finder /conga/story/misc/markets.html195153
Columbus McKinnon Corp. CMCO � shares climbed 9% after the maker of material-handling products reported a return to profitability in its third quarter.
Emulex Corp. ELX � shares rose 15% after the storage-equipment maker late Thursday projected third-quarter results that beat Wall Street�s expectations.
First Solar Inc. FSLR � shares gained more than 11% after Bloomberg reported industry executives from Suntech Power Holdings Co. STP � and Trina Solar Ltd. TSL � said China might double its installations of solar panels in 2012. Suntech shares rose 7.7% and Trina shares rallied 7.3%.
Newell Rubbermaid Inc. NWL �shares advanced 8% after the consumer-products company reported better-than-expected quarterly results.
Solutia Inc. SOA � shares jumped 41% after Eastman Chemical Co. EMN �agreed to buy the specialty-chemical maker in a $3.38 billion cash-and-stock deal. Shares of Eastman Chemical rose almost 7%.
DeclinersCirrus Logic Inc. CRUS � shares slid 8.3% a day after the supplier of parts for Apple products reported fiscal third-quarter results.
DeVry Inc. DV � shares dropped 5.5% after the for-profit educator reported second-quarter adjusted earnings below average analysts� estimates.
Green Dot Corp. GDOT � shares slid 10.5% after the provider of prepaid debit cards late Thursday reported fourth-quarter revenue below expectations.
Infinity Pharmaceuticals Inc. INFI � shares plunged almost 40% after the company halted a mid-stage trial of its potential treatment for pancreatic cancer after data showed patients lived longer taking a placebo.
No comments:
Post a Comment